Bacterial Nanocellulose Membrane As Bolus in Radiotherapy: “Proof of Concept”

Abstract

Bolus characterize materials with an electromagnetic radiation attenuation coefficient similar to biological tissue and which are positioned on the skin of patients during radiotherapy treatment. Such devices are responsible for the superficialization of the maximum dose of high energy photons and electrons, restricting its penetration and improving the coverage of the treatment isodose. The development of new materials, mainly from sustainable biotechnological routes, will contribute to increasing efficiency and expanding the use of these technologies. The objective of this research was to develop the “proof of concept” regarding the use of the bacterial nanocellulose membrane (BNCm) as a bolus for radiotherapy procedures. For this purpose, 1.4 cm thick BNCm were produced from static cultivation of the K. rhaeticus, purified and subjected to the physical‐chemical characterization process by scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FT‐IR). The samples were then subjected to the determination of the radiological density (RD), by computed tomography, and the radiation attenuation potential (%), after being irradiated with 6MV photons in a linear accelerator using ionization and phantom chamber at doses of 100 and 50 UM. The results were compared with data from the analyzes in a commercial bolus (CB) with same thickness. The physical‐chemical analysis demonstrated the constitution of a pure, highly hydrated, homogeneous and nanostructured network of cellulose fibers. The mean RD of BNCm was 1.1 and 5 Hounsfield units respectively, demonstrating high water (0HU) equivalence from BNCm. The values corresponding to the radiation attenuation at the dose of 100 MU were 5.1 ± 0.1% and 4.6 ± 0.2%, for CB and BNCm respectively. The values for the dose of 50 MU were 3.8 ± 0.1% and 3.0 ± 0.2%. In both doses, the attenuation of BNCm was similar to the CB. It stands out the superiority of the BNCm moldability and the possibility to change its composition to improve the radiation attenuation. The results support the concept of use the BNCm as an effective biotechnological device, align to the sustainability idea, as a bolus for radiotherapy treatment.Support or Funding InformationI.P.F.B. Indústria de Produtos Farm. e Biotecnológicos Ltda.